Related references
Note: Only part of the references are listed.Why Statistics Matter: Limited Inter-Rater Agreement Prevents Using the Psoriasis Area and Severity Index as a Unique Determinant of Therapeutic Decision in Psoriasis
Pierre-Antoine Gourraud et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment
J. Berth-Jones et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
The Psoriasis Area and Severity Index is the adequate criterion to define severity in chronic plaque-type psoriasis
J Schmitt et al.
DERMATOLOGY (2005)
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis
CS Carlin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment
RG Langley et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Randomized clinical trials for psoriasis 1977-2000: The EDEN survey
L Naldi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Clearance is not a realistic expectation of psoriasis treatment
SN Al-Suwaidan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Share Paper
